Subsidiary obtaining ZAP Medical Convertible Bond

No.1

Subject: Subsidiary Foxconn (Far East) Limited obtaining Foxteq Holdings Inc. shares

Date of events: 2018/06/27

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g. dividend yield):

Foxteq Holdings Inc. common Shares

2.Date of occurrence of the event: 2018/06/27~2018/06/27

3.Volume, unit price, and total monetary amount of the transaction:

500,000,000 shares at USD0.1 each;total amount equals about USD50,000,000

4.Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):

Foxteq Holdings Inc.;parent and subsidiary companies

5.Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:

Increase by cash in subsidiary's capital

6.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department: Board of Directors

7.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g. pledges):

9,744,237,880 shares；about USD974,423,788；approximately 100%；

restriction of rights:None

8.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:9.72%, to shareholder's equity:28.47%

Operating Capital:NTD-49,014,668,000

9.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

No.2

Subject: Subsidiary Foxteq Holdings Inc.obtaining FABRIGENE LIMITED shares

Date of events: 2018/06/27

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g. dividend yield):

FABRIGENE LIMITED common Shares

2.Date of occurrence of the event: 2018/06/27~2018/06/27

3.Volume, unit price, and total monetary amount of the transaction:

50,000,000 shares at USD1 each;total amount equals about USD50,000,000

4.Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):

FABRIGENE LIMITED;parent and subsidiary companies

5.Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:

Increase by cash in subsidiary's capital

6.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department: Board of Directors

7.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g. pledges):

103,000,000 shares；about USD103,000,000；approximately 100%；

restriction of rights:None

8.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:0.887%, to shareholder's equity:2.598%

Operating Capital:NTD-49,014,668,000

9.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

No.3

Subject: Subsidiary FABRIGENE LIMITED otaining ZAP Medical System, Ltd. Convertible Bond

Date of events: 2018/06/27

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g. dividend yield):

ZAP Medical System, Ltd. Convertible Bond

2.Date of occurrence of the event: 2018/06/27~2018/06/27

3.Volume, unit price, and total monetary amount of the transaction:

53,573,341 shares at USD0.9333 each;total amount equals about USD50,000,000

4.Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):

ZAP Medical System, Ltd.;parent and subsidiary companies

5.Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:

Obtaining ZAP Medical System, Ltd. Convertible Bond

6.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department: Negotiation;Per market price;Board of Directors

7.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g. pledges):

53,573,341 shares；about USD50,000,000；approximately 29.6%；

restriction of rights:None

8.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets: 0.0489%, to shareholder's equity: 0.1433%

Operating Capital:NTD-49,014,668,000

9.Concrete purpose or use of the acquisition or disposal:

Long Term Investment